 | • レポートコード：MRC2-11QY01112 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血友病A治療薬のグローバル市場について調査・分析したレポートです。種類別（ATXF-8117、BAY-1093884、BIVV-001、BS-027125、コンシズマブ、CSL-689、その他）市場規模、用途別（クリニック、病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血友病A治療薬の競争状況、市場シェア ・世界の血友病A治療薬市場：種類別市場規模 2015年-2020年（ATXF-8117、BAY-1093884、BIVV-001、BS-027125、コンシズマブ、CSL-689、その他） ・世界の血友病A治療薬市場：種類別市場規模予測 2021年-2026年（ATXF-8117、BAY-1093884、BIVV-001、BS-027125、コンシズマブ、CSL-689、その他） ・世界の血友病A治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、ASC） ・世界の血友病A治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、ASC） ・北米の血友病A治療薬市場分析：米国、カナダ ・ヨーロッパの血友病A治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血友病A治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血友病A治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血友病A治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer AG、BioMarin Pharmaceutical Inc、Bioverativ Inc、Catalyst Biosciences Inc、Chugai Pharmaceutical Co Ltd、CSL Ltd、DBV Technologies SA、Dimension Therapeutics Inc、EpiVax Inc、Expression Therapeutics LLC、Green Cross Corp、Idogen AB、Immusoft Corp、LFB SA、mAbxience SA ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Hemophilia A Drug Market
The global Hemophilia A Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hemophilia A Drug Scope and Market Size
Hemophilia A Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hemophilia A Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hemophilia A Drug market is segmented into
ATXF-8117
BAY-1093884
BIVV-001
BS-027125
Concizumab
CSL-689
Others
Segment by Application, the Hemophilia A Drug market is segmented into
Clinic
Hospital
ASCs
Regional and Country-level Analysis
The Hemophilia A Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hemophilia A Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hemophilia A Drug Market Share Analysis
Hemophilia A Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hemophilia A Drug business, the date to enter into the Hemophilia A Drug market, Hemophilia A Drug product introduction, recent developments, etc.
The major vendors covered:
Bayer AG
BioMarin Pharmaceutical Inc
Bioverativ Inc
Catalyst Biosciences Inc
Chugai Pharmaceutical Co Ltd
CSL Ltd
DBV Technologies SA
Dimension Therapeutics Inc
EpiVax Inc
Expression Therapeutics LLC
Green Cross Corp
Idogen AB
Immusoft Corp
LFB SA
mAbxience SA
1 Study Coverage
1.1 Hemophilia A Drug Product Introduction
1.2 Market Segments
1.3 Key Hemophilia A Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hemophilia A Drug Market Size Growth Rate by Type
1.4.2 ATXF-8117
1.4.3 BAY-1093884
1.4.4 BIVV-001
1.4.5 BS-027125
1.4.6 Concizumab
1.4.7 CSL-689
1.4.8 Others
1.5 Market by Application
1.5.1 Global Hemophilia A Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 ASCs
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hemophilia A Drug Market Size, Estimates and Forecasts
2.1.1 Global Hemophilia A Drug Revenue 2015-2026
2.1.2 Global Hemophilia A Drug Sales 2015-2026
2.2 Global Hemophilia A Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hemophilia A Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hemophilia A Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hemophilia A Drug Competitor Landscape by Players
3.1 Hemophilia A Drug Sales by Manufacturers
3.1.1 Hemophilia A Drug Sales by Manufacturers (2015-2020)
3.1.2 Hemophilia A Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Hemophilia A Drug Revenue by Manufacturers
3.2.1 Hemophilia A Drug Revenue by Manufacturers (2015-2020)
3.2.2 Hemophilia A Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hemophilia A Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hemophilia A Drug Revenue in 2019
3.2.5 Global Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hemophilia A Drug Price by Manufacturers
3.4 Hemophilia A Drug Manufacturing Base Distribution, Product Types
3.4.1 Hemophilia A Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hemophilia A Drug Product Type
3.4.3 Date of International Manufacturers Enter into Hemophilia A Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hemophilia A Drug Market Size by Type (2015-2020)
4.1.1 Global Hemophilia A Drug Sales by Type (2015-2020)
4.1.2 Global Hemophilia A Drug Revenue by Type (2015-2020)
4.1.3 Hemophilia A Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hemophilia A Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Hemophilia A Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Hemophilia A Drug Revenue Forecast by Type (2021-2026)
4.2.3 Hemophilia A Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hemophilia A Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hemophilia A Drug Market Size by Application (2015-2020)
5.1.1 Global Hemophilia A Drug Sales by Application (2015-2020)
5.1.2 Global Hemophilia A Drug Revenue by Application (2015-2020)
5.1.3 Hemophilia A Drug Price by Application (2015-2020)
5.2 Hemophilia A Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Hemophilia A Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Hemophilia A Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Hemophilia A Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hemophilia A Drug by Country
6.1.1 North America Hemophilia A Drug Sales by Country
6.1.2 North America Hemophilia A Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hemophilia A Drug Market Facts & Figures by Type
6.3 North America Hemophilia A Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Hemophilia A Drug by Country
7.1.1 Europe Hemophilia A Drug Sales by Country
7.1.2 Europe Hemophilia A Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hemophilia A Drug Market Facts & Figures by Type
7.3 Europe Hemophilia A Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hemophilia A Drug by Region
8.1.1 Asia Pacific Hemophilia A Drug Sales by Region
8.1.2 Asia Pacific Hemophilia A Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hemophilia A Drug Market Facts & Figures by Type
8.3 Asia Pacific Hemophilia A Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hemophilia A Drug by Country
9.1.1 Latin America Hemophilia A Drug Sales by Country
9.1.2 Latin America Hemophilia A Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hemophilia A Drug Market Facts & Figures by Type
9.3 Central & South America Hemophilia A Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hemophilia A Drug by Country
10.1.1 Middle East and Africa Hemophilia A Drug Sales by Country
10.1.2 Middle East and Africa Hemophilia A Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hemophilia A Drug Market Facts & Figures by Type
10.3 Middle East and Africa Hemophilia A Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description and Business Overview
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Hemophilia A Drug Products Offered
11.1.5 Bayer AG Related Developments
11.2 BioMarin Pharmaceutical Inc
11.2.1 BioMarin Pharmaceutical Inc Corporation Information
11.2.2 BioMarin Pharmaceutical Inc Description and Business Overview
11.2.3 BioMarin Pharmaceutical Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BioMarin Pharmaceutical Inc Hemophilia A Drug Products Offered
11.2.5 BioMarin Pharmaceutical Inc Related Developments
11.3 Bioverativ Inc
11.3.1 Bioverativ Inc Corporation Information
11.3.2 Bioverativ Inc Description and Business Overview
11.3.3 Bioverativ Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bioverativ Inc Hemophilia A Drug Products Offered
11.3.5 Bioverativ Inc Related Developments
11.4 Catalyst Biosciences Inc
11.4.1 Catalyst Biosciences Inc Corporation Information
11.4.2 Catalyst Biosciences Inc Description and Business Overview
11.4.3 Catalyst Biosciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Catalyst Biosciences Inc Hemophilia A Drug Products Offered
11.4.5 Catalyst Biosciences Inc Related Developments
11.5 Chugai Pharmaceutical Co Ltd
11.5.1 Chugai Pharmaceutical Co Ltd Corporation Information
11.5.2 Chugai Pharmaceutical Co Ltd Description and Business Overview
11.5.3 Chugai Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Products Offered
11.5.5 Chugai Pharmaceutical Co Ltd Related Developments
11.6 CSL Ltd
11.6.1 CSL Ltd Corporation Information
11.6.2 CSL Ltd Description and Business Overview
11.6.3 CSL Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 CSL Ltd Hemophilia A Drug Products Offered
11.6.5 CSL Ltd Related Developments
11.7 DBV Technologies SA
11.7.1 DBV Technologies SA Corporation Information
11.7.2 DBV Technologies SA Description and Business Overview
11.7.3 DBV Technologies SA Sales, Revenue and Gross Margin (2015-2020)
11.7.4 DBV Technologies SA Hemophilia A Drug Products Offered
11.7.5 DBV Technologies SA Related Developments
11.8 Dimension Therapeutics Inc
11.8.1 Dimension Therapeutics Inc Corporation Information
11.8.2 Dimension Therapeutics Inc Description and Business Overview
11.8.3 Dimension Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Dimension Therapeutics Inc Hemophilia A Drug Products Offered
11.8.5 Dimension Therapeutics Inc Related Developments
11.9 EpiVax Inc
11.9.1 EpiVax Inc Corporation Information
11.9.2 EpiVax Inc Description and Business Overview
11.9.3 EpiVax Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 EpiVax Inc Hemophilia A Drug Products Offered
11.9.5 EpiVax Inc Related Developments
11.10 Expression Therapeutics LLC
11.10.1 Expression Therapeutics LLC Corporation Information
11.10.2 Expression Therapeutics LLC Description and Business Overview
11.10.3 Expression Therapeutics LLC Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Expression Therapeutics LLC Hemophilia A Drug Products Offered
11.10.5 Expression Therapeutics LLC Related Developments
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description and Business Overview
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Hemophilia A Drug Products Offered
11.1.5 Bayer AG Related Developments
11.12 Idogen AB
11.12.1 Idogen AB Corporation Information
11.12.2 Idogen AB Description and Business Overview
11.12.3 Idogen AB Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Idogen AB Products Offered
11.12.5 Idogen AB Related Developments
11.13 Immusoft Corp
11.13.1 Immusoft Corp Corporation Information
11.13.2 Immusoft Corp Description and Business Overview
11.13.3 Immusoft Corp Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Immusoft Corp Products Offered
11.13.5 Immusoft Corp Related Developments
11.14 LFB SA
11.14.1 LFB SA Corporation Information
11.14.2 LFB SA Description and Business Overview
11.14.3 LFB SA Sales, Revenue and Gross Margin (2015-2020)
11.14.4 LFB SA Products Offered
11.14.5 LFB SA Related Developments
11.15 mAbxience SA
11.15.1 mAbxience SA Corporation Information
11.15.2 mAbxience SA Description and Business Overview
11.15.3 mAbxience SA Sales, Revenue and Gross Margin (2015-2020)
11.15.4 mAbxience SA Products Offered
11.15.5 mAbxience SA Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hemophilia A Drug Market Estimates and Projections by Region
12.1.1 Global Hemophilia A Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Hemophilia A Drug Revenue Forecast by Regions 2021-2026
12.2 North America Hemophilia A Drug Market Size Forecast (2021-2026)
12.2.1 North America: Hemophilia A Drug Sales Forecast (2021-2026)
12.2.2 North America: Hemophilia A Drug Revenue Forecast (2021-2026)
12.2.3 North America: Hemophilia A Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Hemophilia A Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Hemophilia A Drug Sales Forecast (2021-2026)
12.3.2 Europe: Hemophilia A Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Hemophilia A Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hemophilia A Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hemophilia A Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hemophilia A Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hemophilia A Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Hemophilia A Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Hemophilia A Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Hemophilia A Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Hemophilia A Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hemophilia A Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hemophilia A Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hemophilia A Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hemophilia A Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hemophilia A Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hemophilia A Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Hemophilia A Drug Market Segments
Table 2. Ranking of Global Top Hemophilia A Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hemophilia A Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ATXF-8117
Table 5. Major Manufacturers of BAY-1093884
Table 6. Major Manufacturers of BIVV-001
Table 7. Major Manufacturers of BS-027125
Table 8. Major Manufacturers of Concizumab
Table 9. Major Manufacturers of CSL-689
Table 10. Major Manufacturers of Others
Table 11. Global Hemophilia A Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Hemophilia A Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Hemophilia A Drug Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Hemophilia A Drug Sales Market Share by Regions (2015-2020)
Table 15. Global Hemophilia A Drug Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Hemophilia A Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Hemophilia A Drug Sales Share by Manufacturers (2015-2020)
Table 18. Global Hemophilia A Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Hemophilia A Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia A Drug as of 2019)
Table 20. Hemophilia A Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Hemophilia A Drug Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Hemophilia A Drug Price (2015-2020) (USD/Pcs)
Table 23. Hemophilia A Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Hemophilia A Drug Product Type
Table 25. Date of International Manufacturers Enter into Hemophilia A Drug Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Hemophilia A Drug Sales by Type (2015-2020) (K Pcs)
Table 28. Global Hemophilia A Drug Sales Share by Type (2015-2020)
Table 29. Global Hemophilia A Drug Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Hemophilia A Drug Revenue Share by Type (2015-2020)
Table 31. Hemophilia A Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Hemophilia A Drug Sales by Application (2015-2020) (K Pcs)
Table 33. Global Hemophilia A Drug Sales Share by Application (2015-2020)
Table 34. North America Hemophilia A Drug Sales by Country (2015-2020) (K Pcs)
Table 35. North America Hemophilia A Drug Sales Market Share by Country (2015-2020)
Table 36. North America Hemophilia A Drug Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Hemophilia A Drug Revenue Market Share by Country (2015-2020)
Table 38. North America Hemophilia A Drug Sales by Type (2015-2020) (K Pcs)
Table 39. North America Hemophilia A Drug Sales Market Share by Type (2015-2020)
Table 40. North America Hemophilia A Drug Sales by Application (2015-2020) (K Pcs)
Table 41. North America Hemophilia A Drug Sales Market Share by Application (2015-2020)
Table 42. Europe Hemophilia A Drug Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Hemophilia A Drug Sales Market Share by Country (2015-2020)
Table 44. Europe Hemophilia A Drug Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Hemophilia A Drug Revenue Market Share by Country (2015-2020)
Table 46. Europe Hemophilia A Drug Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Hemophilia A Drug Sales Market Share by Type (2015-2020)
Table 48. Europe Hemophilia A Drug Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Hemophilia A Drug Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Hemophilia A Drug Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Hemophilia A Drug Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Hemophilia A Drug Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Hemophilia A Drug Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Hemophilia A Drug Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Hemophilia A Drug Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Hemophilia A Drug Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Hemophilia A Drug Sales Market Share by Application (2015-2020)
Table 58. Latin America Hemophilia A Drug Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Hemophilia A Drug Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Hemophilia A Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Hemophilia A Drug Revenue Market Share by Country (2015-2020)
Table 62. Latin America Hemophilia A Drug Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Hemophilia A Drug Sales Market Share by Type (2015-2020)
Table 64. Latin America Hemophilia A Drug Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Hemophilia A Drug Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Hemophilia A Drug Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Hemophilia A Drug Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Hemophilia A Drug Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Hemophilia A Drug Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Hemophilia A Drug Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Hemophilia A Drug Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Hemophilia A Drug Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Hemophilia A Drug Sales Market Share by Application (2015-2020)
Table 74. Bayer AG Corporation Information
Table 75. Bayer AG Description and Major Businesses
Table 76. Bayer AG Hemophilia A Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Bayer AG Product
Table 78. Bayer AG Recent Development
Table 79. BioMarin Pharmaceutical Inc Corporation Information
Table 80. BioMarin Pharmaceutical Inc Description and Major Businesses
Table 81. BioMarin Pharmaceutical Inc Hemophilia A Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. BioMarin Pharmaceutical Inc Product
Table 83. BioMarin Pharmaceutical Inc Recent Development
Table 84. Bioverativ Inc Corporation Information
Table 85. Bioverativ Inc Description and Major Businesses
Table 86. Bioverativ Inc Hemophilia A Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Bioverativ Inc Product
Table 88. Bioverativ Inc Recent Development
Table 89. Catalyst Biosciences Inc Corporation Information
Table 90. Catalyst Biosciences Inc Description and Major Businesses
Table 91. Catalyst Biosciences Inc Hemophilia A Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Catalyst Biosciences Inc Product
Table 93. Catalyst Biosciences Inc Recent Development
Table 94. Chugai Pharmaceutical Co Ltd Corporation Information
Table 95. Chugai Pharmaceutical Co Ltd Description and Major Businesses
Table 96. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Chugai Pharmaceutical Co Ltd Product
Table 98. Chugai Pharmaceutical Co Ltd Recent Development
Table 99. CSL Ltd Corporation Information
Table 100. CSL Ltd Description and Major Businesses
Table 101. CSL Ltd Hemophilia A Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. CSL Ltd Product
Table 103. CSL Ltd Recent Development
Table 104. DBV Technologies SA Corporation Information
Table 105. DBV Technologies SA Description and Major Businesses
Table 106. DBV Technologies SA Hemophilia A Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. DBV Technologies SA Product
Table 108. DBV Technologies SA Recent Development
Table 109. Dimension Therapeutics Inc Corporation Information
Table 110. Dimension Therapeutics Inc Description and Major Businesses
Table 111. Dimension Therapeutics Inc Hemophilia A Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Dimension Therapeutics Inc Product
Table 113. Dimension Therapeutics Inc Recent Development
Table 114. EpiVax Inc Corporation Information
Table 115. EpiVax Inc Description and Major Businesses
Table 116. EpiVax Inc Hemophilia A Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. EpiVax Inc Product
Table 118. EpiVax Inc Recent Development
Table 119. Expression Therapeutics LLC Corporation Information
Table 120. Expression Therapeutics LLC Description and Major Businesses
Table 121. Expression Therapeutics LLC Hemophilia A Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Expression Therapeutics LLC Product
Table 123. Expression Therapeutics LLC Recent Development
Table 124. Green Cross Corp Corporation Information
Table 125. Green Cross Corp Description and Major Businesses
Table 126. Green Cross Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Green Cross Corp Product
Table 128. Green Cross Corp Recent Development
Table 129. Idogen AB Corporation Information
Table 130. Idogen AB Description and Major Businesses
Table 131. Idogen AB Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Idogen AB Product
Table 133. Idogen AB Recent Development
Table 134. Immusoft Corp Corporation Information
Table 135. Immusoft Corp Description and Major Businesses
Table 136. Immusoft Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Immusoft Corp Product
Table 138. Immusoft Corp Recent Development
Table 139. LFB SA Corporation Information
Table 140. LFB SA Description and Major Businesses
Table 141. LFB SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 142. LFB SA Product
Table 143. LFB SA Recent Development
Table 144. mAbxience SA Corporation Information
Table 145. mAbxience SA Description and Major Businesses
Table 146. mAbxience SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 147. mAbxience SA Product
Table 148. mAbxience SA Recent Development
Table 149. Global Hemophilia A Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 150. Global Hemophilia A Drug Sales Market Share Forecast by Regions (2021-2026)
Table 151. Global Hemophilia A Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 152. Global Hemophilia A Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 153. North America: Hemophilia A Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 154. North America: Hemophilia A Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Europe: Hemophilia A Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 156. Europe: Hemophilia A Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Asia Pacific: Hemophilia A Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 158. Asia Pacific: Hemophilia A Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 159. Latin America: Hemophilia A Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 160. Latin America: Hemophilia A Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 161. Middle East and Africa: Hemophilia A Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 162. Middle East and Africa: Hemophilia A Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 163. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 164. Key Challenges
Table 165. Market Risks
Table 166. Main Points Interviewed from Key Hemophilia A Drug Players
Table 167. Hemophilia A Drug Customers List
Table 168. Hemophilia A Drug Distributors List
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemophilia A Drug Product Picture
Figure 2. Global Hemophilia A Drug Sales Market Share by Type in 2020 & 2026
Figure 3. ATXF-8117 Product Picture
Figure 4. BAY-1093884 Product Picture
Figure 5. BIVV-001 Product Picture
Figure 6. BS-027125 Product Picture
Figure 7. Concizumab Product Picture
Figure 8. CSL-689 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Hemophilia A Drug Sales Market Share by Application in 2020 & 2026
Figure 11. Clinic
Figure 12. Hospital
Figure 13. ASCs
Figure 14. Hemophilia A Drug Report Years Considered
Figure 15. Global Hemophilia A Drug Market Size 2015-2026 (US$ Million)
Figure 16. Global Hemophilia A Drug Sales 2015-2026 (K Pcs)
Figure 17. Global Hemophilia A Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Hemophilia A Drug Sales Market Share by Region (2015-2020)
Figure 19. Global Hemophilia A Drug Sales Market Share by Region in 2019
Figure 20. Global Hemophilia A Drug Revenue Market Share by Region (2015-2020)
Figure 21. Global Hemophilia A Drug Revenue Market Share by Region in 2019
Figure 22. Global Hemophilia A Drug Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Hemophilia A Drug Revenue in 2019
Figure 24. Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Hemophilia A Drug Sales Market Share by Type (2015-2020)
Figure 26. Global Hemophilia A Drug Sales Market Share by Type in 2019
Figure 27. Global Hemophilia A Drug Revenue Market Share by Type (2015-2020)
Figure 28. Global Hemophilia A Drug Revenue Market Share by Type in 2019
Figure 29. Global Hemophilia A Drug Market Share by Price Range (2015-2020)
Figure 30. Global Hemophilia A Drug Sales Market Share by Application (2015-2020)
Figure 31. Global Hemophilia A Drug Sales Market Share by Application in 2019
Figure 32. Global Hemophilia A Drug Revenue Market Share by Application (2015-2020)
Figure 33. Global Hemophilia A Drug Revenue Market Share by Application in 2019
Figure 34. North America Hemophilia A Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Hemophilia A Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Hemophilia A Drug Sales Market Share by Country in 2019
Figure 37. North America Hemophilia A Drug Revenue Market Share by Country in 2019
Figure 38. U.S. Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Hemophilia A Drug Market Share by Type in 2019
Figure 43. North America Hemophilia A Drug Market Share by Application in 2019
Figure 44. Europe Hemophilia A Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Hemophilia A Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Hemophilia A Drug Sales Market Share by Country in 2019
Figure 47. Europe Hemophilia A Drug Revenue Market Share by Country in 2019
Figure 48. Germany Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Hemophilia A Drug Market Share by Type in 2019
Figure 59. Europe Hemophilia A Drug Market Share by Application in 2019
Figure 60. Asia Pacific Hemophilia A Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Hemophilia A Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Hemophilia A Drug Sales Market Share by Region in 2019
Figure 63. Asia Pacific Hemophilia A Drug Revenue Market Share by Region in 2019
Figure 64. China Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Hemophilia A Drug Market Share by Type in 2019
Figure 87. Asia Pacific Hemophilia A Drug Market Share by Application in 2019
Figure 88. Latin America Hemophilia A Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Hemophilia A Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Hemophilia A Drug Sales Market Share by Country in 2019
Figure 91. Latin America Hemophilia A Drug Revenue Market Share by Country in 2019
Figure 92. Mexico Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Hemophilia A Drug Market Share by Type in 2019
Figure 99. Latin America Hemophilia A Drug Market Share by Application in 2019
Figure 100. Middle East and Africa Hemophilia A Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Hemophilia A Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Hemophilia A Drug Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Hemophilia A Drug Revenue Market Share by Country in 2019
Figure 104. Turkey Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Hemophilia A Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Hemophilia A Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Hemophilia A Drug Market Share by Type in 2019
Figure 111. Middle East and Africa Hemophilia A Drug Market Share by Application in 2019
Figure 112. North America Hemophilia A Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Hemophilia A Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Hemophilia A Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Hemophilia A Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Hemophilia A Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Hemophilia A Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Hemophilia A Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Hemophilia A Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Hemophilia A Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Hemophilia A Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
血友病A・B組換え因子補充療法の世界市場（～2026年） Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…- 血友病治療薬の世界市場（～2026年） Hemophilia is a rare disorder in which your blood doesn't clot normally because it lacks sufficient blood-clotting proteins (clotting factors). Market Analysis and Insights: Global Hemophilia Treatment Drugs Market The global Hemophilia Treatment Drugs market size is projected to reach US$ 11160 mil…
- 血友病薬の世界市場（～2026年） The hemophilia treatment drugs market is experiencing entry of a large number of new drugs in the market. Few of them have already arrived and other long lasting clotting factors and more promising drugs are on their way to get launched in this market. For instance, follow up data from phase I/II st…
- 特殊医薬品流通の世界市場（～2026年） Specialty Drug Distribution is a link of pharmaceutical logistics; it distributes Specialty Drug to consumers relying on certain logistics equipment, technology and logistics management information system. Specialty drugs play an increasingly important role in the treatment of chronic conditions suc…
- 小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…